Internal Medicine, Infectious Disease · Tampa, FL
NPI
1164695904
Since 2008
Specialty
Internal Medicine, Infectious Disease
Code 207RI0200X
Group practices
1
Medicare group memberships
Hospitals
5
Hospital affiliations
4729 N Habana Ave
Tampa, FL, 33614
Phone (813) 251-8444
Groups this clinician bills Medicare through
Medicare paid, 2024
$157K
212,344 services
Medicare patients, 2024
501
Average age 74
Drug cost, 2024
$1.6M
1,343 prescriptions
Company payments, 2025
$1,014
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Yagneshvari S Patel was code 99232 (hospital e&m - subsequent), 1,149 times for 353 patients. In total Yagneshvari S Patel billed 212,344 services in 36 codes, and Medicare paid $157K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2022-08-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99232 Hospital E&M - Subsequent | Facility | 1,149 | 353 | $59.95 | $69K |
| 96365 Intravenous Infusion, Hydration | Office | 395 | 22 | $46.92 | $19K |
| 99222 Hospital E&M - Initial | Facility | 252 | 238 | $97.53 | $25K |
| 99231 Hospital E&M - Subsequent | Facility | 172 | 132 | $37.67 | $6,478 |
| 99214 Office E&M - Established | Office | 105 | 60 | $85.27 | $8,953 |
| 36415 Venipuncture Blood Collection | Office | 33 | 23 | $8.65 | $285 |
| G0181 Physician or allowed practitioner supervision of a patient receiving medicare-covered services provided by a participating home health agency (patient not present) requiring complex and multidisciplinary care modalities involving regular physician or allow | Office | 32 | 28 | $81.23 | $2,599 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 30 | 19 | $11.89 | $357 |
| 99223 Hospital E&M - Initial | Facility | 27 | 25 | $134.90 | $3,642 |
| 99233 Hospital E&M - Subsequent | Facility | 26 | 22 | $88.90 | $2,312 |
By year: 2022 $139K for 18,994 services; 2023 $142K for 93,803 services; 2024 $157K for 212,344 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 33 | 23 | $8.65 | $285 |
Medicare prescription drug claims, 2024
In 2024, the drug Yagneshvari S Patel prescribed most often to Medicare patients was Vancomycin Hcl, with 118 prescriptions and refills. In total Yagneshvari S Patel wrote 1,343 Medicare prescriptions that cost $1.6M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Vancomycin Hcl Generic | 118 | 118 | 42 | $21K |
| Doxycycline Hyclate Generic | 91 | 108 | 50 | $2,219 |
| Cefepime Hcl Generic | 83 | 83 | 22 | $14K |
| Ceftriaxone Ceftriaxone Sodium | 70 | 70 | 19 | $9,387 |
| Ciprofloxacin Hcl Generic | 65 | 67 | 31 | $1,045 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 56 | 61 | 19 | $3,079 |
| Biktarvy Bictegrav/Emtricit/Tenofov Ala | 49 | 49 | Under 11 | $218K |
| Triumeq Abacavir/Dolutegravir/Lamivudi | 46 | 46 | Under 11 | $167K |
| Tivicay Dolutegravir Sodium | 42 | 42 | Under 11 | $135K |
| Ertapenem Ertapenem Sodium | 36 | 36 | 14 | $14K |
| Daptomycin Generic | 35 | 35 | Under 11 | $15K |
| Rifampin Generic | 33 | 45 | Under 11 | $1,040 |
| Meropenem Generic | 32 | 32 | Under 11 | $3,282 |
| Genvoya Elviteg/Cob/Emtri/Tenof Alafen | 27 | 27 | Under 11 | $112K |
| Descovy Emtricitabine/Tenofov Alafenam | 26 | 26 | Under 11 | $57K |
Brand drugs: 426 claims; generic drugs: 917 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Yagneshvari S Patel $1,014 ($1,014 in general payments such as food, travel and fees) from 12 companies. The largest payer was Gilead Sciences, Inc. with $311.
| Company | Payments | Amount |
|---|---|---|
| Gilead Sciences, Inc. GILD | 14 | $311 |
| ViiV Healthcare Company GSK | 12 | $267 |
| Merck Sharp & Dohme LLC MRK | 6 | $104 |
| Theratechnologies Inc. THTX | 3 | $81.58 |
| Insmed, Inc. INSM | 3 | $68.46 |
| Shionogi Inc 4507.T | 3 | $53.52 |
| Abbvie Inc. ABBV | 1 | $26.09 |
| Aimmune Therapeutics, Inc. | 1 | $25.7 |
| Electromed, Inc. ELMD | 2 | $24.84 |
| La Jolla Pharmaceutical Company | 1 | $20.26 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.